The role of surgical margins in treatment of Ewing's sarcoma family tumors: Experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 3, 2006, Pages 766-772

  Bacci, Gaetano ^a   Longhi, Alessandra ^a   Briccoli, Antonio ^b   Bertoni, Franco ^c   Versari, Michela ^a   Picci, Piero ^d  

^a Chemotherapy   (Italy)

^b Istituti Ortopedici Rizzoli   (Italy)

^c Department of Musculoskeletal Oncology   (Italy)

^d Laboratory of Oncologic Research   (Italy)

Author keywords

Ewing's sarcoma; Extremity; Neoadjuvant chemotherapy; Radiotherapy; Surgery

Indexed keywords

BIOMEDICAL ENGINEERING; PATIENT TREATMENT; RADIOTHERAPY; SURGERY;

EWING'S SARCOMA; EXTREMITY; NEOADJUVANT CHEMOTHERAPY;

TUMORS;

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; EWING SARCOMA; FAMILIAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; SARCOMA, EWING'S; TREATMENT OUTCOME;

EID: 33646937193     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.01.019     Document Type: Article

References (31)

1. Rosen G., Caparros B., Mosende C., et al. Curability of Ewing's sarcoma and considerations for future therapeutic trials. Cancer 41 (1978) 888-899
2. Jurgens H., Exner U., Gadner H., et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 61 (1988) 23-32
3. Burgert Jr. E.O., Nesbit M.E., Garnsey L.A., et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone. Intergroup study IESS-II. J Clin Oncol 8 (1990) 1514-1524
4. Donaldson S.S., Torrey M., Link M.P., et al., Pediatric Oncology Group. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma. End results of POG #8346. Int J Radiat Oncol Biol Phys 42 (1998) 125-135
5. Nesbit Jr. M.E., Gehan E.A., Burgert Jr. E.O., et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone. A long-term follow-up of the First Intergroup Study. J Clin Oncol 8 (1990) 1664-1674
6. Oberlin O., Habrand J.L., Zucker J.M., et al. No benefit of ifosfamide in Ewing's sarcoma. A nonrandomized study of the French Society of Pediatric Oncology. J Clin Oncol 10 (1992) 1407-1412
7. Craft A.W., Cotterill S., and Imeson J. Improvement in survival for Ewing's sarcoma by substitution of ifosfamide for cyclophosphamide. Am J Pediatr Hematol Oncol 15 (1993) 31-35
8. Craft A.W., Cotterill S.J., Bullimore J.A., et al. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33 (1997) 1061-1069
9. Paulussen M., Ahrens S., Dunst J., et al. Localized Ewing tumor of bone. Final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19 (2001) 1818-1829
10. Elomaa I., Blomqvist C.P., Saeter G., et al. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Eur J Cancer 36 (2000) 875-880
11. Grier H.E., Krailo M.D., Tarbell N.J., et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 (2003) 694-701
12. Bacci G., Ferrari S., Longhi A., et al. Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery. J Bone Joint Surg Br 85 (2003) 107-114
13. Bacci G., Ferrari S., Longhi A., et al. Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy. Oncol Rep 11 (2004) 111-120
14. Ozaki T., Hillmann A., Hoffmann C., et al. Significance of surgical margins on the prognosis of patients with Ewing's sarcoma. Cancer 78 (1996) 892-900
15. Bacci G., Ferrari S., Bertoni F., et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy. Analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 18 (2000) 4-11
16. Kuttesch J.F., Wexler L.H., Marcus R.B., et al. Second malignancies after Ewing's sarcoma. Radiation dose-dependency of secondary sarcoma. J Clin Oncol 14 (1996) 2818-2825
17. Gobel V., Jurgens H., Etspuler G., et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 113 (1987) 187-191
18. Enneking W., Dunham W., Gebhardt M., et al. A system for the classification of skeletal resections. Chir Organi Mov 75 (1990) 217-240
19. Picci P., Rougraff B.T., Bacci G., et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 11 (1993) 1763-1769
20. Kotz R., Ritschl P., and Trachtenbrodt J. Modular femur-tibia reconstruction system. Orthopedics 9 (1986) 1639-1652
21. Winkelmann W.W. Hip rotationplasty for malignant tumors of the proximal part of the femur. J Bone Joint Surg (Am) 68 (1986) 362-369
22. Schiller C., Windhager R., Fellinger E.J., et al. Extendable tumor endoprostheses for the leg in children. J Bone Joint Surg (Br) 77 (1997) 608-614
23. Grimer R.J., Belthur M., Carter S.R., et al. Extendible replacements of the proximal tibia for bone tumours. Bone Joint Surg (Br) 82 (2000) 255-260
24. Eckardt J.J., Kabo J.M., Kelley C.M., et al. Expandable endoprosthesis reconstruction in skeletally immature patients with tumors. Clin Orthop Rel Res 373 (2000) 51-61
25. Manfrini M. The role of vascularized fibula in skeletal reconstruction. Chir Organi Mov 88 (2003) 137-142
26. Schuck A., Ahrens S., Paulussen M., et al. Local therapy in localized Ewing tumors. Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 55 (2003) 168-177
27. Tefft M., Razek A., Perez C., et al. Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. Int J Radiat Oncol Biol Phys 4 (1978) 367-372
28. Bacci G., Campanacci M., and Pagani P.A. Adjuvant chemotherapy in the treatment of clinically localised Ewing's sarcoma. J Bone Joint Surg (Br) 60-B (1978) 567-574
29. Nesbit Jr. M.E., Perez C.A., Tefft M., et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone. An Intergroup Study. Natl Cancer Inst Monogr 56 (1981) 255-262
30. Oberlin O., Patte C., Demeocq F., et al. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Eur J Cancer Clin Oncol 21 (1985) 463-467
31. Krasin M.J., Rodriguez-Galindo C., Davidoff A.M., et al. Efficacy of combined surgery and irradiation for localized Ewing's sarcoma family of tumors. Pediatr Blood Cancer 43 (2004) 229-236